
    
      This will be a randomized, open-label, 3-way crossover design study to assess the drug-drug
      interaction between a single oral dose of ASP1941 and a single oral dose of Miglitol in
      healthy adult male volunteers. Each subject will receive "ASP1941 alone", "Miglitol alone"
      and "ASP1941 + Miglitol".
    
  